Where does Medaxis AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medaxis AG ranks #26,825 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medaxis AG hold?

Medaxis AG holds 10 US utility patents granted between 2018 and 2024, spanning 9 technology areas.

What is Medaxis AG's Innovation Score?

Medaxis AG has an Innovation Score of 27.3 out of 100 (23rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medaxis AG focus on?

Medaxis AG's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 8 patents, ranking #2,086 of 7,127 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Medaxis AG's patent grant rate increasing or decreasing?

Medaxis AG's recent grant velocity is +133% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Medaxis AG's patents?

Medaxis AG's patents average 12.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medaxis AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medaxis AG

USPTO PatentsView assignee record - 10 granted patents across 9 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medaxis ranks #26,825 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 9 technology areas.

#26,825
of 49,997 US assignees by volume: 23rd percentile
by Innovation Score (27.3/100): 12.1
avg claims per patent: +133%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26825 · Foreign Corporation #26,825 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,825/49,997
PHOTO-FINISH MDF Instruments USA
CPC-NARROW A61B · 9 areas
INNOV-THIN 27.3/100
CLAIMS-RICH 12.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +133% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: MDF Instruments USA LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medaxis’s 27.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (30%) Velocity 1.1 pts (4%) Breadth 10.6 pts (39%) Claim depth 7.3 pts (27%)

Qualcomm Incorporated · highest

85
Medaxis · this assignee

27
3D Lighting… · lowest

7

What this shows Medaxis's Innovation Score is 27.3/100 (23rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medaxis?

Each dot is one of Medaxis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medaxis’s own 12.1 claims/patent is at or below the 12.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Medaxis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medaxis's grants concentrate

Medaxis AG is a focused PatentsView assignee: 9 CPC subclasses with 80% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2024. By volume, Medaxis sits between MDF Instruments USA LLC and MEI, LLC.

Medaxis's three-year grant acceleration

Medaxis AG shows 1 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

MDF Instruments U…

10
Mdxhealth

10
Meat & Livestock…

10
Mecs

10
Media Fast LC

10
Medsolve

10
Mego Afek AC

10
MEI

10
Medaxis ◀

10

What this shows Medaxis holds 10 patents at rank #26,799, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medaxis

By rank, the assignees closest to #26,799 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medaxis's primary technology class.

Medaxis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 23rd percentile higher than 23% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Medaxis AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	3	30.0%
2020	3	30.0%
2021	3	30.0%
2024	1	10.0%

Which technologies does Medaxis AG patent most?

A61B - DIAGNOSIS; SURGERY; Identification 8

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 3

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

B24C - Abrasive OR Related Blasting With Particulate Material 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

B08B - Cleaning IN GENERAL; Prevention OF Fouling IN General 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medaxis AG's patent record in context - here's where to go next.

Medaxis AG's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 80% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #26,825 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medaxis AG against MDF Instruments USA LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.